1 / 21

Calcium Antagonists

Calcium Antagonists. Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823. Regulation of Ca 2+ extrusion. Ca 2+ -ATPase. Na + -driven Ca 2+ antiport. Ca 2+. Ca 2+. 2 mM. Na +. ATP. ADP. 100 nM. ADP. ATP. Ca 2+ -ATPase. Ca 2+. Ca 2+. Ca 2+. Mitochondria. Ca 2+ -binding

libitha
Download Presentation

Calcium Antagonists

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

  2. Regulation of Ca2+ extrusion Ca2+-ATPase Na+ -driven Ca2+ antiport Ca2+ Ca2+ 2 mM Na+ ATP ADP 100 nM ADP ATP Ca2+-ATPase Ca2+ Ca2+ Ca2+ Mitochondria Ca2+-binding proteins Ca2+-sequestering compartments

  3. Regulation of Ca2+ entry Receptor-dependent Ca2+ entry R Gq PLCb IP3 DAG Polarized Voltage-dependent Ca2+ channel Closed Depolarized Open-inactive Open-active

  4. SS a1 a2 g d b Subunit composition of L-type Ca2+ channel • L-type (long-lasting)-excitation/contraction coupling of cardiac myocytes (nifedipine, verapamil, diltiazem) • T-type (transient) - participate in pace making, highly expressed in sinusal cells (mibefradil) • N-, P-type - expressed in neurons, are not affected by Ca2+ antagonists

  5. Ca2+ channels Ca2+ (intracellular) Ca2+ - calmodulin complex P MLCK Myosin light chain Myosin-actin interaction Contraction Control of smooth muscle contraction and the site of action of calcium channel-blocking drugs Ca2+ channels blockers Calmodulin

  6. Calcium Antagonists • Bind to specific sites on the alpha1 subunit of the L-type Ca2+ channel • Reduce the probability of channel opening rather then calcium current flow through an open channel • Tissue selectivity is one of the most beneficial properties of Ca2+ antagonists • In general, skeletal muscle, bronchial, tracheal, and intestinal smooth muscle and neuronal tissue are relatively insensitive to Ca2+ antagonists

  7. SMOOTH MUSCLE • Relaxation due to Ca2+ decrease • Decrease in blood pressure • Decrease in vascular resistance CARDIAC MUSCLE * Excitation/contraction * Impulse generation in sinoatrial node * Conduction in atrioventricalar node Require Ca2+ influx DECREASE IN OXYGEN REQUIREMENT

  8. VASCULAR SELECTIVITY IMPROVED HEART PERFORMANCE INCREASED DECREASED CORONARY PERFUSION PERIPHERAL RESISTANCE AFTERLOAD FLOW BP CONTRACTION IMPROVED OXYGEN SUPPLY ENERGY SAVING

  9. Degree of tissue selectivity of calcium antagonist in clinical use myocardium vessels sino-atrial node + + + verapamil + + + diltiazem ++ - + nifedipine +++ - + nimodipine ++++ - + felodipine ++++ - + nisoldipine ++++ - + amlodipine Amlodipine is currently the most commonly prescribed calcium blocker for hypertension

  10. Angina and Calcium Antagonists • Angina is a chest pain that occurs when coronary blood flow is inadequate to supply the oxygen required by heart • Classic angina is caused by atherosclerosis • Angiospastic or variant angina is caused by vasospasm

  11. Angina and Calcium Antagonists • VASODILATION Can be used in Prinzmetal’ angina Effective at coronary vasospasm Not recommended in unstable angina or MI • INCREASED OXYGEN SUPPLY Myocardial oxygen extraction is almost maximal ~75% of the available oxygen under no stress condition, thus there is no reserve to meet increased demand. The increased demand is me by increasing coronary blood flow • DECREASE OXYGEN DEMAND Three major determinants of the myocardial oxygen uptake are heart rate, blood pressure, and the contractile status of the myocardium

  12. Angina and Calcium Antagonists Calcium Antagonists • Reduce blood pressure because of peripheral vasodilation • Reduce heart rate, especially diltiazem and verapamil • Decrease contractility thereby reducing the oxygen demand

  13. Hypertension and Calcium Antagonists • Mechanism of action is VASODILATION • Nifedipine is used commonly because is 10 times more selective to vascular smooth muscle cells than to myocardial cells • Often used in patients with contraindications to beta-antagonists

  14. Arrhythmia and Calcium Antagonists Arrhythmia results from • Abnormal pacemaker activity • Abnormal impulse propagation Aim of therapy • To reduce ectopic pacemaker activity • To modify impulse propagation

  15. Arrhythmia and Calcium Antagonists Supraventricular dysrhythmia(diltiazem, verapamil) • Mechanism of action is selectivity for pacemaker and nodal cells. Blocks Ca2+-dependent conduction in AV node, thereby reducing atrioventricular conduction • Restores synapse rhythm in 75% cases

  16. Other Uses • Migraine • Prevent development of atheromatous lesions • Pulmonary artery hypertension

  17. Side Effects Diltiazem • Edema • Headache • Depresses sinoatrial nodal function because of high degree atrioventricular nodal block Nifedipine • Dizziness is the result of acute vasodilation and rapid blood pressure fall • Headaches is the result of vasodilation • Ankle edema is caused by precapillary vasodilation Verapamil • May increase digoxin level when used in combination • Absolutely contraindicated in digoxin toxicity because will cause high grade AV block • High rate of constipation up to 30%, presumably due to a specific interaction of verapamil with calcium channels in smooth muscle cells of the gut • Depresses sinoatrial nodal function, may cause high degree atrioventricular nodal block

  18. Contraindications • Patients with low baseline blood pressure • may develop hypotension • Patients with decreased left ventricular • systolic function - may worsen the heart failure • Arrythmias with antegrade conduction down • a bypass tract, such as • syndrome Wolff-Parkinson-White

More Related